Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis
- PMID: 22142548
- DOI: 10.1111/j.1440-1746.2011.07043.x
Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis
Abstract
Background and aim: Refractory ascites in liver-cirrhosis is associated with a poor prognosis. We performed a prospective study to investigate whether aggressive nutritional-support could improve outcomes in cirrhotic patients.
Methods: Cirrhotic patients undergoing serial large-volume paracentesis for refractory-ascites were enrolled and randomized into three groups. Group A received post-paracentesis intravenous nutritional-support in addition to a balanced oral diet and a late-evening protein snack, group B received the same oral nutritional-protocol as the first group but without parenteral support, and group C (the control group) received a low-sodium or sodium-free diet. Clinical, anthropometric and laboratory nutritional parameters and biochemical tests of liver and renal function were reported for 12 months of follow-up.
Results: We enrolled 120 patients, who were randomized into three groups of equal size. Patients on the nutritional-protocol showed better preservation of clinical, anthropometric and laboratory nutritional parameters that were associated with decreased deterioration of liver function compared with patients on the low-sodium or sodium-free diet (group C). Groups A and B had lower morbidity and mortality rates than the control group (C). Mortality rates were significantly better in patients who were treated with parenteral-nutritional-support than for the other two groups. In patients who were on the nutritional-protocol, there was a reduction in the requirement of taps for the treatment of refractory ascites.
Conclusions: Post-paracentesis parenteral-nutritional-support with a balanced oral diet and an evening protein snack appears to be the best care protocol for patients with liver-cirrhosis that has been complicated by refractory-ascites.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Similar articles
-
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.Gastroenterology. 2002 Dec;123(6):1839-47. doi: 10.1053/gast.2002.37073. Gastroenterology. 2002. PMID: 12454841 Clinical Trial.
-
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.N Engl J Med. 2000 Jun 8;342(23):1701-7. doi: 10.1056/NEJM200006083422303. N Engl J Med. 2000. PMID: 10841872 Clinical Trial.
-
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5. Hepatogastroenterology. 2003. PMID: 14696397
-
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.Liver Int. 2010 Aug;30(7):937-47. doi: 10.1111/j.1478-3231.2010.02272.x. Epub 2010 May 21. Liver Int. 2010. PMID: 20492521 Review.
-
Review article: Management of ascites and associated complications in patients with cirrhosis.Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:183-93. doi: 10.1111/j.1365-2036.2007.03482.x. Aliment Pharmacol Ther. 2007. PMID: 18081661 Review.
Cited by
-
Do Nutritional Interventions Improve the Outcomes of Patients with Cirrhosis and Ascites: A Systematic Review of Randomized Trials.Curr Hepatol Rep. 2020 Jun;19(2):71-77. doi: 10.1007/s11901-020-00513-1. Epub 2020 Apr 22. Curr Hepatol Rep. 2020. PMID: 33473347 Free PMC article.
-
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.Qual Life Res. 2018 Jun;27(6):1513-1520. doi: 10.1007/s11136-018-1813-8. Epub 2018 Feb 19. Qual Life Res. 2018. PMID: 29460201 Clinical Trial.
-
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis.Nutrients. 2023 Aug 5;15(15):3471. doi: 10.3390/nu15153471. Nutrients. 2023. PMID: 37571408 Free PMC article. Review.
-
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.Clin Mol Hepatol. 2018 Sep;24(3):230-277. doi: 10.3350/cmh.2018.1005. Epub 2018 Jul 9. Clin Mol Hepatol. 2018. PMID: 29991196 Free PMC article. Review. No abstract available.
-
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.Nutrients. 2023 Dec 21;16(1):35. doi: 10.3390/nu16010035. Nutrients. 2023. PMID: 38201864 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical